{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:19Z","timestamp":1761102199929,"version":"3.40.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":289,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Netherlands CardioVascular Research Initiative","award":["CVON2014-2"],"award-info":[{"award-number":["CVON2014-2"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.atherosclerosis.2016.01.031","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T20:58:38Z","timestamp":1453237118000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Serum CETP concentration is not associated with measures of body fat: The NEO study"],"prefix":"10.1016","volume":"246","author":[{"given":"Lisanne L.","family":"Blauw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e","family":"de Mutsert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildo J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"de Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-0458","authenticated-orcid":false,"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko Willems","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-4988","authenticated-orcid":false,"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib3","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice","volume":"26","author":"Westerterp","year":"2006","journal-title":"Arterioscler. thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib4","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(14)61009-6","article-title":"LDL cholesterol: controversies and future therapeutic directions","volume":"384","author":"Ridker","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35018119","article-title":"A\u00a0cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits","volume":"406","author":"Okamoto","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(07)61813-3","article-title":"Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies","volume":"370","author":"Krishna","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(15)60158-1","article-title":"Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"386","author":"Hovingh","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib9","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1016\/S0021-9258(20)64369-1","article-title":"Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA","volume":"266","author":"Jiang","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/327632a0","article-title":"Cloning and sequencing of human cholesteryl ester transfer protein cDNA","volume":"327","author":"Drayna","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0925-4439(99)00091-5","article-title":"Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues","volume":"1500","author":"Dusserre","year":"2000","journal-title":"Biochim. biophys. acta"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9150(98)00051-3","article-title":"Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man","volume":"139","author":"Radeau","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib13","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/S0022-2275(20)41091-0","article-title":"Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content","volume":"36","author":"Radeau","year":"1995","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2362.1994.tb00987.x","article-title":"Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism","volume":"24","author":"Dullaart","year":"1994","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11745-009-3285-7","article-title":"Plasma lipid transfer enzymes in non-diabetic lean and obese men and women","volume":"44","author":"Magkos","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/meta.2003.50045","article-title":"Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat","volume":"52","author":"Greaves","year":"2003","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib17","first-page":"1129","article-title":"Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity","volume":"14","author":"Arai","year":"1994","journal-title":"Arterioscler. thromb. a J. Vasc. biol. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib18","first-page":"247","article-title":"Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification","volume":"42","author":"Ritsch","year":"2004","journal-title":"Clin. Chem. lab. Med. CCLM\/FESCC"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0009-8981(94)90199-6","article-title":"Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP)","volume":"231","author":"Guyard-Dangremont","year":"1994","journal-title":"Clin. chim. acta. Int. J. Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib20","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/hep.27985","article-title":"Plasma cholesteryl ester transfer protein is predominantly derived from kupffer cells","volume":"62","author":"Wang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10654-013-9801-3","article-title":"The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection","volume":"28","author":"de Mutsert","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ajcn\/58.4.489","article-title":"Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol","volume":"58","author":"Feunekes","year":"1993","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0895-4356(03)00220-8","article-title":"Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity","volume":"56","author":"Wendel-Vos","year":"2003","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2105\/AJPH.81.9.1166","article-title":"Epidemiologic studies utilizing surveys: accounting for the sampling design","volume":"81","author":"Korn","year":"1991","journal-title":"Am. J. public health"},{"year":"2004","series-title":"Analysis of Complex Survey Samples","author":"Lumley","key":"10.1016\/j.atherosclerosis.2016.01.031_bib26"},{"year":"2013","series-title":"Hoeveel Mensen Hebben Overgewicht?","author":"Ministerie van V.W.S","key":"10.1016\/j.atherosclerosis.2016.01.031_bib27"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2105\/AJPH.85.5.726","article-title":"Predicting body fatness: the body mass index vs estimation by bioelectrical impedance","volume":"85","author":"Roubenoff","year":"1995","journal-title":"Am. J. public health"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ijo.0800961","article-title":"Body mass index (weight\/height2) or percentage body fat by bioelectrical impedance analysis: which variable better reflects serum lipid profile?","volume":"23","author":"Nagaya","year":"1999","journal-title":"Int. J. Obes. Relat. metabolic Disord. J. Int. Assoc. Study Obes."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2016.01.031_bib30","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1038\/ejcn.2012.168","article-title":"The use of bioelectrical impedance analysis for body composition in epidemiological studies","volume":"67","author":"Bohm","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/sj.ijo.0800467","article-title":"Visceral fat in relation to health: is it a major culprit or simply an innocent bystander?","volume":"21","author":"Seidell","year":"1997","journal-title":"Int. J. Obes. Relat. metabolic Disord. J. Int. Assoc. Study Obes."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bcp.2012.06.020","article-title":"Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice","volume":"84","author":"Li","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2003.11.020","article-title":"The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia","volume":"173","author":"de Grooth","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib34","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1194\/jlr.M700108-JLR200","article-title":"Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression","volume":"48","author":"van der Hoogt","year":"2007","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib35","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/ATVBAHA.108.171363","article-title":"Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice","volume":"28","author":"van der Hoorn","year":"2008","journal-title":"Arterioscler. thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur. heart J."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2003.08.025","article-title":"Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia","volume":"171","author":"Caslake","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/oby.20583","article-title":"Body composition in 18- to 88-year-old adults\u2013comparison of multifrequency bioimpedance and dual-energy X-ray absorptiometry","volume":"22","author":"Sillanpaa","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib39","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.2337\/dc11-0685","article-title":"Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes care"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/oby.2006.119","article-title":"Early decreases in plasma lipid transfer proteins during weight reduction","volume":"14","author":"Tzotzas","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib41","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1194\/jlr.P900015-JLR200","article-title":"Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women","volume":"51","author":"Asztalos","year":"2010","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI8573","article-title":"Sterol upregulation of human CETP expression in\u00a0vitro and in transgenic mice by an LXR element","volume":"105","author":"Luo","year":"2000","journal-title":"J.\u00a0Clin. investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2010.04.025","article-title":"LXRalpha regulates human CETP expression in\u00a0vitro and in transgenic mice","volume":"212","author":"Honzumi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib46","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"year":"2015","series-title":"Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease","author":"Eli Lilly and Company","key":"10.1016\/j.atherosclerosis.2016.01.031_bib47"},{"key":"10.1016\/j.atherosclerosis.2016.01.031_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ijo.2011.100","article-title":"Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity","volume":"36","author":"Gomez-Ambrosi","year":"2012","journal-title":"Int. J. Obes."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T23:46:46Z","timestamp":1654127206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016300302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":48,"alternative-id":["S0021915016300302"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.031","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum CETP concentration is not associated with measures of body fat: The NEO study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}